Antioxidants improve antibacterial function in hyperoxia-exposed macrophages

Area of Science:

• Pulmonary medicine
• Immunology
• Neonatal research

Background:

• Hyperoxia and pulmonary infections are known risk factors for neonatal lung injury.
• The direct impact of hyperoxia on pneumonia risk in newborns remains unclear.

Purpose of the Study:

• To investigate hyperoxia's effects on mononuclear cell inflammation and bacterial clearance.
• To compare neonatal and adult mononuclear cell responses to hyperoxia.
• To evaluate the role of antioxidant enzymes in mitigating hyperoxia-induced impairment.

Main Methods:

• Mouse macrophages exposed to room air or 95% oxygen (hyperoxia).
• Incubation with Pseudomonas aeruginosa to assess bacterial adherence and phagocytosis.
• Analysis of macrophage inflammatory protein (MIP)-1alpha production.
• Comparison of hyperoxia effects on neonatal and adult monocytes.

Main Results:

• Hyperoxia significantly increased bacterial adherence (5.8-fold) and MIP-1alpha production (49%), while decreasing phagocytosis (60%).
• Overexpression of manganese superoxide dismutase (MnSOD) or catalase reduced bacterial adherence.
• MnSOD significantly improved phagocytosis and reduced inflammation, outperforming catalase.
• Adult monocytes showed greater phagocytic impairment under hyperoxia than neonatal monocytes.

Conclusions:

• Hyperoxia impairs mononuclear cell function, increasing bacterial adherence and potentially pneumonia risk.
• MnSOD demonstrates potential in reducing hyperoxia-induced inflammation and improving bacterial clearance.
• Neonatal monocytes exhibit more resilience to hyperoxia-induced impairment than adult monocytes.
• Targeting oxidant-induced lung injury with MnSOD may reduce neonatal lung injury and nosocomial infections.